ey0017.12-1 | Type 2 Diabetes | ESPEYB17
C Sardu , N DOnofrio , ML, et al. Balestrieri
ey0017.12-7 | Type 2 Diabetes | ESPEYB17
Z Obermeyer , B Powers , C, et al. Vogeli
ey0017.13-5 | Advocacy, History and Society | ESPEYB17
J Guevara-Aguirre , C Guevara , A Guevara , AA Gavilanes
ey0017.14-6 | (1) | ESPEYB17
B-C Bjork , S Kanto-Karvonen , JT Harviainen
ey0016.8-12 | New Genes | ESPEYB16
L Ben Aim , P Pigny , LJ Castro-Vega , A Buffet , L Amar , J Bertherat , D Drui , I Guilhem , E Baudin , C Lussey-Lepoutre , C Corsini , G Chabrier , C Briet , L Faivre , C Cardot-Bauters , J Favier , AP Gimenez-Roqueplo , N Burnichon
ey0016.11-7 | Tracking, Programming, and Epigenetics | ESPEYB16
S Lecoutre , P Petrus , M Ryden , C Breton
ey0016.12-8 | Metabolic Syndrome | ESPEYB16
G Kroemer , C Lopez-Otin , F Madeo , R de Cabo
ey0015.1-11 | Reviews | ESPEYB15
P Beck-Peccoz , G Rodari , C Giavoli , A Lania
ey0015.6-9 | New hope | ESPEYB15
D Chen , L Simons , EK Johnson , BA Lockart , C Finlayson
ey0015.6-17 | Psychological aspects | ESPEYB15
F D'Alberton , S Vissani , C Ferracuti , V Pasterski